Skip navigation
Perspectives on building technology businesses and AcceleratorIndia from Cartezia

Healthcare and Bio-pharma

The Indian Healthcare and Bio-Pharma sector is undergoing dramatic change. In urban areas, healthcare delivery is being transformed rapidly by the emergence of multi-tiered health service providers, ranging from the big hospital groups to smaller specialist providers of general and specialist healthcare. In rural areas central and state government initiatives such as the National Rural Health Mission are transforming the delivery of healthcare services. In bio-pharma, innovations are impacting new treatments, medical devices and new interventions. Our objective is to provide practical guidance on all these developments and provide support for better decision-making.

Featured article:

Rethinking Cross-border Innovation

Our research has identified three generic cross-border challenges based on the Triple Chasm Model:Cross-border R&D or Technology Translation;Cross-border Chasm II Translation;and Cross-border Chasm III Translation More »

Thursday, July 27, 2017

Overview of the Indian Medical Devices Market

The Indian medical devices industry constitutes around 8% of the Indian healthcare sector and was worth about US$6.3 billion in 2013. The industry is highly fragmented with 65% of manufacturing attributable to SMEs and the higher-end of the market dominated by foreign manufacturers with... More »

Friday, June 27, 2014

Overview of the Indian Wound Care Market

The wound care market can be segmented into the following categories: Traditional Wound Care; Basic Wound Care; Advanced Wound Care; Active Wound Care; and Wound Care Therapy Devices. The Indian market is growing rapidly consistent with other sectors of the Indian Healthcare market. The total... More »

Friday, June 27, 2014

Indian Pharma: an industry in rapid transition

The Indian pharma market is in a state of rapid transition. Following the introduction of product patents, several multinational companies are expected to launch patented drugs in India, notwithstanding residual anxieties about compulsory licensing. The Indian market is also set to change with... More »

Friday, June 27, 2014

<< BackNext >>Page 1 of 4